Posttreatment interleukin-2 in patients with acute myeloid leukemia: the end of a long road for patients and clinical trials?
about
Posttreatment interleukin-2 in patients with acute myeloid leukemia: the end of a long road for patients and clinical trials?
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
Posttreatment interleukin-2 in ...... patients and clinical trials?
@en
Posttreatment interleukin-2 in ...... patients and clinical trials?
@nl
type
label
Posttreatment interleukin-2 in ...... patients and clinical trials?
@en
Posttreatment interleukin-2 in ...... patients and clinical trials?
@nl
prefLabel
Posttreatment interleukin-2 in ...... patients and clinical trials?
@en
Posttreatment interleukin-2 in ...... patients and clinical trials?
@nl
P2860
P356
P1433
P1476
Posttreatment interleukin-2 in ...... patients and clinical trials?
@en
P2093
Dolores Grosso
Mark A Weiss
P2860
P304
P356
10.1002/CNCR.28514
P407
P577
2013-12-31T00:00:00Z